Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as those promised ...

A recent study reveals a surge in the use of GLP-1 medications, such as Ozempic and Wegovy, among younger age groups.

A Cleveland Clinic study shows that semaglutide and tirzepatide – injectable GLP-1 drugs for obesity – produce smaller weight ...

SEATTLE -- Weight loss drugs have gained momentum as treatment for obstructive sleep apnea (OSA) at sleep clinics across the ...

That's according to the study funded by ... taking semaglutide. The GLP-1 drugs have become increasingly popular, with at least 1 in 8 U.S. adults reporting their use, according to a 2024 survey ...

Semaglutide and other GLP-1 agonists ... The study's limitations include the use of self-reported data and the lack of a control group. Dr. Gudbergsen concludes, "Our results show that by giving ...

A new study indicates that certain GLP-1 weight-loss drugs can help ... Wegovy is approved for use in weight management. Semaglutide drugs are available as both oral tablets and injections.

Less than 3% of all people in the U.S. who are eligible for injectable weight loss drugs receive a prescription for it, according to a new study from ... like peptide-1 (GLP-1) agonists are ...

Early animal studies have indicated that GLP-1 drugs can help cut alcohol cravings, but studies involving humans are only starting to emerge, researchers said. For this study, researchers tracked ...

Glucagon-like peptide-1 (GLP-1) analogues, drugs developed ... ‘effortless’.” The study’s limitations include the relatively small number of patients, the use of self-reported alcohol ...